[Expert Solution]: A patient with a life-threatening disease…

A patient with a life-threatening disease has exhausted all available treatment options but is not able to participate in the phase 3 trial of a promising new drug because of geographic location. The phase 3 trial is completed and demonstrated a favorable benefit-risk profile. The patient asks her oncologist if there is a way to get the new drug. What is the best option for this patient? A. The oncologist could enroll the patient in an Expanded Access or Compassionate Use programB. The oncologist could initiate a small, independent, phase 2 study at his institution and treat the patientC. The oncologist could obtain the drug directly from the manufacturerD. The patient could go to another country to get the drugE. The patient would have to wait until the drug is approved